1. University of Kragujevac Digital Archive
  2. University of Kragujevac
  3. Faculty of Medical Sciences, Kragujevac
Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/16298
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStojkovic Andjelkovic, Andjelka-
dc.contributor.authorMilovanovic, Dragan-
dc.contributor.authorStojanović, Boban-
dc.contributor.authorDajic K.-
dc.contributor.authorElek Z.-
dc.contributor.authorVulovic, Maja-
dc.contributor.authorSimovic, Aleksandra-
dc.date.accessioned2023-02-08T16:54:50Z-
dc.date.available2023-02-08T16:54:50Z-
dc.date.issued2019-
dc.identifier.issn0370-8179-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/16298-
dc.description.abstractIntroduction The laryngeal hemangioma in children is a benign vascular neoplasm but it could become malignant after localization. Case outline After two weeks of corticosteroid treatment in a 15-month-old boy, there were no desired results. This case report is a small contribution to the research of targeted Propranolol treatment in infantile laryngeal hemangioma and the role of Epinephrine in the initial treatment in life-threatening conditions. Conclusion When laryngeal hemangioma has “bad” localization and any surgical treatment is denied in spite of the vital risk, the choices of treatment are epinephrine (as the first choice) and propranolol.-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.sourceSrpski Arhiv za Celokupno Lekarstvo-
dc.titleThe treatment of hemangioma of the larynx in children is still a dilemma-
dc.typearticle-
dc.identifier.doi10.2298/SARH180209059S-
dc.identifier.scopus2-s2.0-85069297911-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

809

Downloads(s)

12

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access		29.86 kBAdobe PDFThumbnail
View/Open
Show simple item record


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.